Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. (Q37029796)
Jump to navigation
Jump to search
scientific article published on 18 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. |
scientific article published on 18 February 2016 |
Statements
1 reference
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. (English)
1 reference
Raymond T Chung
1 reference
Tracey G Simon
1 reference
Hector Bonilla
1 reference
Peng Yan
1 reference
Adeel A Butt
1 reference
18 February 2016
1 reference
1 reference
47-57
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference